{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T08:24:17Z","timestamp":1794385457236,"version":"4.9.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"27","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPD"],"published-print":{"date-parts":[[2018,12,3]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Inflammatory bowel disease (IBD) is a group of disorders characterized by chronic inflammation\nwithin the gastrointestinal tract. It is a multifactorial disease associated with immune-cell mediated oxidative\ndamage to the intestinal mucosa. There is no cure for IBD, but anti-cytokine therapy can limit target inflammation\nand disease progression. Unfortunately, many patients are nonresponsive or develop resistance to anti-cytokine\ntherapy over time creating a need for new therapeutic agents. Metallothionein (MT) is a small, highly conserved\nstress response protein that has been shown to modulate the immune response as a pro-inflammatory agent, regulates\ndivalent heavy metal homeostasis, and acts as a reactive metabolite scavenger. Our research, as well as other\ngroups studying MT, has described MT induction and release during IBD inflammatory stress response. The\nrelease of MT results in activation of inflammatory responses leading to progressive inflammation and subsequent\nexpansion of MT synthesis. A monoclonal antibody specific for MT has been used in murine models of IBD and\nshould only target the extracellular pool of MT, thus representing a novel therapeutic approach to this disease.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1381612824666180717110236","type":"journal-article","created":{"date-parts":[[2018,7,17]],"date-time":"2018-07-17T12:03:28Z","timestamp":1531829008000},"page":"3155-3161","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Metallothionein: A Novel Therapeutic Target for Treatment of Inflammatory Bowel Disease"],"prefix":"10.2174","volume":"24","author":[{"given":"Kristen E.","family":"Dostie","sequence":"first","affiliation":[{"name":"Department of Molecular and Cell Biology, University of Connecticut, Storrs, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy V.","family":"Thees","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cell Biology, University of Connecticut, Storrs, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Lynes","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cell Biology, University of Connecticut, Storrs, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/163819","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/163819\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/163819","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,25]],"date-time":"2020-12-25T19:52:48Z","timestamp":1608925968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/163819\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,3]]},"references-count":0,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2018,12,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1381612824666180717110236","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-04-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}